Pelthos Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 3.88, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Pelthos Therapeutics Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 94 days, from 91 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector Pelthos Therapeutics Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Pelthos Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PTHS Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	3.88	3.99	3.71	-	-
PTHS's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	94	92	98	-	-
Seq. Receivable Change	32.08 %	10.89 %	-	-	-
Seq. Revenue Change	16.16 %	26.78 %	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

PTHS Company Profile • Back to PTHS Efficiency Comparisons • Compare PTHS Receivables Turnover Ratio to its Competitors

Financial Statements
Pelthos Therapeutics Inc 's Accounts Receivable	$ 12 Millions	Visit PTHS's Balance sheet
Pelthos Therapeutics Inc 's Sales TTM	$ 28 Millions	Visit PTHS's Income Statement
Sources of PTHS's Revenues		Visit PTHS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PTHS's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PTHS's Growth Rates	PTHS's Roa	PTHS's Inventory Turnover Ratio	PTHS's Dividend Comparisons
PTHS's Profitability Ratios	PTHS's Roi	PTHS's Asset Turnover Ratio	PTHS's Dividend Growth
PTHS's Valuation Ratios	PTHS's Roe	PTHS's Financial Strength Ratios	PTHS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Haemonetics Corporation	6.50	$ 1,333.586 Millions	$ 205.095 Millions
Vivos Inc	6.48	$ 0.078 Millions	$ 0.012 Millions
Intellia Therapeutics Inc	6.45	$ 66.092 Millions	$ 10.251 Millions
Rapid Micro Biosystems Inc	6.44	$ 33.753 Millions	$ 5.245 Millions
Bruker Corporation	6.40	$ 3,457.300 Millions	$ 540.275 Millions
Rigel Pharmaceuticals Inc	6.39	$ 299.767 Millions	$ 46.885 Millions
Opko Health Inc	6.39	$ 581.123 Millions	$ 90.962 Millions
Delcath Systems Inc	6.37	$ 89.081 Millions	$ 13.984 Millions
Baxter International Inc	6.37	$ 11,320.000 Millions	$ 1,777.250 Millions
Adaptive Biotechnologies Corporation	6.29	$ 295.407 Millions	$ 46.947 Millions
Medicinova Inc	6.29	$ 0.597 Millions	$ 0.095 Millions
Renovorx Inc	6.26	$ 1.489 Millions	$ 0.238 Millions
Select Medical Holdings Corp	6.22	$ 5,521.134 Millions	$ 887.240 Millions
Emergent Biosolutions Inc	6.22	$ 676.800 Millions	$ 108.775 Millions
Adm Tronics Unlimited Inc	6.22	$ 3.347 Millions	$ 0.538 Millions
Harvard Bioscience Inc	6.22	$ 84.970 Millions	$ 13.665 Millions
Neogen Corporation	6.21	$ 871.509 Millions	$ 140.236 Millions
Lakeland Industries Inc	6.20	$ 193.318 Millions	$ 31.179 Millions
Vertex Pharmaceuticals Inc	6.20	$ 12,218.000 Millions	$ 1,972.200 Millions
Heartflow Inc	6.19	$ 189.487 Millions	$ 30.604 Millions
Zoetis Inc	6.16	$ 9,509.000 Millions	$ 1,544.250 Millions
Pacira Biosciences inc	6.13	$ 734.864 Millions	$ 119.835 Millions
Neuroone Medical Technologies Corp	6.12	$ 9.721 Millions	$ 1.588 Millions
Labcorp Holdings Inc	6.11	$ 14,144.200 Millions	$ 2,313.275 Millions
Keros Therapeutics Inc	6.11	$ 42.450 Millions	$ 6.944 Millions
Novavax inc	6.11	$ 596.338 Millions	$ 97.582 Millions
Treace Medical Concepts Inc	6.11	$ 207.318 Millions	$ 33.951 Millions
Ispecimen inc	6.09	$ 1.027 Millions	$ 0.169 Millions
Gilead Sciences Inc	6.09	$ 29,736.000 Millions	$ 4,882.500 Millions
Pacific Health Care Organization Inc	6.09	$ 6.394 Millions	$ 1.051 Millions

Date modified: 2026-08-30T15:06:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.